KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Receivables (2016 - 2026)

Medtronic (MDT) has disclosed Change in Receivables for 13 consecutive years, with -$13.0 million as the latest value for Q1 2026.

  • Quarterly Change in Receivables fell 533.33% to -$13.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $162.0 million through Jan 2026, down 62.76% year-over-year, with the annual reading at $433.0 million for FY2025, 10.74% up from the prior year.
  • Change in Receivables hit -$13.0 million in Q1 2026 for Medtronic, down from $214.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $435.0 million in Q4 2022 to a low of -$288.0 million in Q3 2025.
  • Historically, Change in Receivables has averaged $95.2 million across 5 years, with a median of $62.0 million in 2023.
  • Biggest five-year swings in Change in Receivables: soared 232.06% in 2022 and later plummeted 533.33% in 2026.
  • Year by year, Change in Receivables stood at $435.0 million in 2022, then tumbled by 35.4% to $281.0 million in 2023, then grew by 3.56% to $291.0 million in 2024, then decreased by 26.46% to $214.0 million in 2025, then tumbled by 106.07% to -$13.0 million in 2026.
  • Business Quant data shows Change in Receivables for MDT at -$13.0 million in Q1 2026, $214.0 million in Q4 2025, and -$288.0 million in Q3 2025.